Why Encompass Health (EHC) is a Top Value Stock for the Long-Term

Zacks Investment Research highlights Encompass Health Corporation (EHC) as a compelling value stock, assigning it a #1 (Strong Buy) Zacks Rank and a VGM Score of A. EHC's attractiveness is further supported by a Value Style Score of B, driven by a forward P/E ratio of 23.9, and a consensus EPS estimate for fiscal year 2025 increasing by $0.22 to $5.01 following upward revisions from eight analysts.

Analysis

Encompass Health Corporation (EHC) has been identified as a compelling investment opportunity, securing a Zacks Rank #1 (Strong Buy) and a VGM Score of A, indicative of strong overall prospects. The company's Value Style Score of B is supported by attractive valuation metrics, notably a forward P/E ratio of 23.9, which suggests it may be undervalued relative to its earnings potential. Reinforcing this positive outlook, eight analysts have revised their fiscal year 2025 earnings estimates for EHC upward within the past 60 days, leading to an increase in the Zacks Consensus Estimate by $0.22 to $5.01 per share. Furthermore, EHC has demonstrated a consistent ability to outperform expectations, evidenced by an average earnings surprise of 12.3%. As a provider of integrated healthcare services through its extensive network of 166 inpatient rehabilitation hospitals across 38 states and Puerto Rico, EHC is well-positioned to benefit from the growing prevalence of coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements, which favor high-quality, cost-effective care.

Key Decisions for Investors

• Investors should consider Encompass Health (EHC) for inclusion in portfolios, particularly those with a value-oriented investment strategy, given its #1 Zacks Rank, A-rated VGM Score, and B-rated Value Score.
• The positive trend in earnings estimate revisions for fiscal 2025 and a consistent history of earnings surprises suggest a favorable outlook that may warrant a bullish stance.
• Monitor the company's ability to capitalize on the shift towards integrated care models and maintain its cost-effective service delivery, as these are key drivers for its continued growth and valuation.